E/M Coding Alert - 2006 Issue 7
DRUG REIMBURSEMENT: How To Use The Three New 'J' Modifiers In The Drug Vendor Program
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS guidance related to the Competitive Acquisition Program for Part B drugs and the practical concerns it raises for participating physicians and practices. It discusses broad operational topics such as emergency access to drugs, vendor supply issues, inventory management, and the Medicare billing modifiers introduced in the guidance. The piece is relevant to physicians, oncology and other specialty practices, reimbursement staff, and anyone tracking Medicare drug payment policy.
Why This Topic Matters
The article helps readers understand how CMS responded to implementation concerns in the drug vendor program and what kinds of reimbursement and workflow issues practices may encounter. It is useful for teams that need to follow Medicare Part B drug policy changes and assess the administrative impact on drug acquisition and billing.
Article Sections
-
CMS will let you use a non-vendor drug in emergencies
Introduces CMS guidance on Part B drug access under the vendor program and the broad situations in which practices may need alternative supply arrangements.
-
What the CAP Changes Mean For You
Summarizes practitioner reactions, operational concerns, and broader commentary on how the program may affect participating practices and vendors.
What You Will Learn
- The CMS guidance discussed in the article
- How the drug vendor program affects participating physicians and practices
- The operational and reimbursement concerns raised by the CAP
- Which broad billing modifier updates are part of the discussion
Who Should Read This
- Physicians
- Medical practice managers
- Reimbursement coordinators
- Billing staff
- Oncology practices
- Clinical specialty groups tracking Medicare policy
Codes Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com